Wall Street Access Asset Management, LLC Rigel Pharmaceuticals Inc Transaction History

Wall Street Access Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.22 - $3.45 $177,600 - $276,000	-80,000 Reduced 80.0%	20,000 $59,000
Q1 2021 May 13, 2021	SELL	$3.35 - $4.93 $43,550 - $64,089	-13,000 Reduced 11.5%	100,000 $342,000
Q3 2020 Nov 13, 2020	BUY	$1.78 - $4.13 $201,140 - $466,690	113,000 New	113,000 $271,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Wall Street Access Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wall Street Access Asset Management, LLC with notifications on news.